Senate Finance & Appropriations Committee: Support SB 278

SB 278 costs taxpayers $0 and ensures that Community Health Centers can remain open and continue providing access to affordable, life-saving medication to over 422,000 Virginians.

VA2026SB 278

Drug manufacturers; permitting and registration, certain conditions related to 340B-covered drugs.

Last Action

Reported from Finance and Appropriations with substitute (15-Y 0-N)

Senate • Feb 11, 2026

Latest Version

Education and Health Substitute

Take action now

What's your district & how can legislators reach you?

Tell us about yourself

Your Message to the legislators

Dear (name and title inserted automatically),

On behalf of Virginia’s Federally Qualified Health Centers (FQHCs)—which operate more than 210 locations and serve over 422,000 patients annually across the Commonwealth—I am writing to respectfully request your support for SB 278, legislation that protects patient access to affordable medications through the federal 340B Drug Pricing Program.

Virginia's FQHCs have lost more than $33 million in 340B savings in 2024 and $106 million since 2020, when these shipping restrictions began. These restrictions are fueling an access crisis for low-income Virginians. In many communities, patients are now forced to travel longer distances to fill their prescriptions—passing multiple pharmacies along the way.

SB 278 protects patient access by ensuring that drug manufacturers cannot restrict 340B shipments to contract pharmacies for Virginia's community health centers.

We respectfully urge you to support SB 278 to protect access to affordable, life-saving medications and preserve the integrity of the 340B program for the patients and communities who rely on it most.

Thank you for your leadership and for your continued support of Virginia’s community health centers. Please let us know if we can provide any additional information or serve as a resource as the Committee considers this legislation.